​Emkay has initiated coverage on Epigral with a Buy rating and the June 25E target price of Rs 2,000 (20X June 26E EPS).
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
​Emkay has initiated coverage on Epigral with a Buy rating and the June 25E target price of Rs 2,000 (20X June 26E EPS).
| Subscribe To Our Free Newsletter |
